JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.

JPXHealthcareMedical - Instruments & Supplies
最新数据
JP¥445
+JP¥4.00 · +0.91%
最新数据
JP¥445
+JP¥4.00 · +0.91%
盘中时间采用JST。市场数据可能有所延迟。
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
日内区间
当前JP¥445
52周区间
当前JP¥445
盘中时间采用JST。市场数据可能有所延迟。
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
日内区间
当前JP¥445
52周区间
当前JP¥445
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(JPY) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 658.45亿 JPY | 697.49亿 JPY | 652.92亿 JPY | 637.4亿 JPY | 581.69亿 JPY |
| 销货成本 | 504.89亿 JPY | 538.24亿 JPY | 511.98亿 JPY | 491.45亿 JPY | 438.99亿 JPY |
| 毛利 | 153.56亿 JPY | 159.25亿 JPY | 140.94亿 JPY | 145.95亿 JPY | 142.7亿 JPY |
| 研究与开发 | — | — | 15.18亿 JPY | 13.18亿 JPY | 15.31亿 JPY |
| 销售、一般及管理费用 | 149.73亿 JPY | 150.51亿 JPY | 124.45亿 JPY | 121.23亿 JPY | 113.73亿 JPY |
| 营业费用 | 149.73亿 JPY | 150.51亿 JPY | 143.62亿 JPY | 138.69亿 JPY | 132.88亿 JPY |
| 利息收入 | 3100万 JPY | 1900万 JPY | 1400万 JPY | 1200万 JPY | 700万 JPY |
| 利息支出 | 4.07亿 JPY | 3.4亿 JPY | 2.2亿 JPY | 1.67亿 JPY | 1.59亿 JPY |
| 折旧和摊销 | 38.33亿 JPY | 38.88亿 JPY | 37.14亿 JPY | 35.93亿 JPY | 33.59亿 JPY |
| 营业利润 | 3.83亿 JPY | 8.74亿 JPY | −2.68亿 JPY | 7.24亿 JPY | 9.8亿 JPY |
| 净利润 | −7.84亿 JPY | 8900万 JPY | −3600万 JPY | 2.81亿 JPY | 8.26亿 JPY |
公司数据更新于 2026年10月10日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
JP¥17.00
2025年(完整年度)0.0% 自从 2021
2026年(部分年度):JP¥17.00
JP¥17.00
2,021
JP¥17.00
2,022
JP¥17.00
2,023
JP¥17.00
2,024
JP¥17.00
2,025
JP¥17.00
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息即将实施 | 2027年3月30日 | JP¥8.50Semi-Annual | 2027年3月31日 | 2027年3月30日 |
股息 | 2026年9月29日 | JP¥8.50Semi-Annual | 2026年9月30日 | 2026年9月29日 |
股息 | 2026年3月30日 | JP¥8.50Semi-Annual | 2026年3月31日 | 2026年6月24日 |
股息 | 2025年9月29日 | JP¥8.50Semi-Annual | 2025年9月30日 | 2025年12月10日 |
股息 | 2025年3月28日 | JP¥8.50Semi-Annual | 2025年3月31日 | 2025年6月25日 |
股息 | 2024年9月27日 | JP¥8.50Semi-Annual | 2024年9月30日 | 2024年12月10日 |
除息 2027年3月30日
JP¥8.50
Semi-Annual
2027年3月31日登记 · 支付日 2027年3月30日
除息 2026年9月29日
JP¥8.50
Semi-Annual
2026年9月30日登记 · 支付日 2026年9月29日
除息 2026年3月30日
JP¥8.50
Semi-Annual
2026年3月31日登记 · 支付日 2026年6月24日
除息 2025年9月29日
JP¥8.50
Semi-Annual
2025年9月30日登记 · 支付日 2025年12月10日
除息 2025年3月28日
JP¥8.50
Semi-Annual
2025年3月31日登记 · 支付日 2025年6月25日
除息 2024年9月27日
JP¥8.50
Semi-Annual
2024年9月30日登记 · 支付日 2024年12月10日
报告持有此股票敞口的交易所交易基金。
NEXT FUNDS TOPIX Exchange Traded Fund1306.T2.54亿0.00%35.13万亿 JPY0.05%JP¥432.5+0.70%
iShares Core TOPIX ETF1475.T2381.4万0.00%3.01万亿 JPY0.05%JP¥425.6+0.45%
Dimensional - International Small Cap Value ETFDISV5.27万0.00%50.56亿 USD0.42%US$42.645+0.46%
Dimensional - International Core Equity 2 ETFDFIC4.89万0.00%150.17亿 USD0.22%US$37.53+0.64%
Dimensional World ex U.S. Core Equity 2 ETFDFAX2.84万0.00%123.36亿 USD0.28%US$37.08+0.76%
Dimensional - International Small Cap ETFDFIS8919.510.00%57.5亿 USD0.39%US$36.03+0.92%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
iShares Core TOPIX ETF1475.T
Dimensional - International Small Cap Value ETFDISV
Dimensional - International Core Equity 2 ETFDFIC
Dimensional World ex U.S. Core Equity 2 ETFDFAX
Dimensional - International Small Cap ETFDFISAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。